Anondita Medicare Ltd. is poised for a robust debut on the NSE SME platform this Monday, with market indicators suggesting significant potential gains for investors.

IPO Performance

The Initial Public Offering (IPO) of Anondita Medicare Ltd. has garnered substantial interest from investors, achieving an impressive oversubscription of nearly 301 times. The offering received bids for over 95.53 crore shares against the 31.73 lakh shares on offer, reflecting strong demand across investor categories.

Grey Market Premium Indicates Strong Listing

The grey market, often considered a barometer for listing day performance, is showing a premium of Rs 89 for Anondita Medicare shares. This premium suggests an expected listing price of Rs 234.00 per share, a significant increase from the upper price band of Rs 145.00 set during the IPO.

Potential Gains for Investors

Based on the grey market premium, investors could potentially see gains of 61.38% on the listing day. However, it's important to note that grey market premiums are unofficial and not guaranteed.

IPO Details

Utilization of Funds

The company plans to use the proceeds from the IPO for several key purposes:

1. Capital expenditure on equipment
2. Meeting working capital requirements
3. General corporate purposes

Investors and market watchers will be closely monitoring Anondita Medicare's debut on the NSE SME platform this Monday, as it marks another addition to the growing list of small and medium enterprises accessing public markets for growth capital.

Anondita Medicare, a Noida-based manufacturer of flavored condoms, has concluded its Initial Public Offering (IPO) with remarkable success. The Rs 69.5 crore IPO witnessed an extraordinary oversubscription of more than 300 times, showcasing strong investor interest in the company's shares.

Overwhelming Investor Response

The IPO garnered over 2.88 lakh applications across various investor categories:

• Retail investors: 286.20 times oversubscribed
• Non-institutional investors: 531.82 times oversubscribed
• Qualified Institutional Buyers (QIBs): 153.03 times oversubscribed

This overwhelming response indicates significant investor confidence in Anondita Medicare's business model and growth prospects.

Grey Market Premium and Listing Details

The grey market premium for Anondita Medicare shares currently stands at 55%, suggesting potential listing gains for successful applicants. Key dates for investors to note:

• August 29: Refunds for unsuccessful applicants and share credits to demat accounts of successful applicants
• Upcoming Monday: Scheduled listing on NSE SME platform

Company Overview

Anondita Medicare specializes in manufacturing flavored male and female condoms under the 'COBRA' brand. The company boasts an impressive annual production capacity of 562 million units. Its market reach extends beyond India, with exports to Southeast Asia, Africa, and the Middle East.

Financial Performance

The company has reported strong financial results:

This substantial 327% jump in profit after tax demonstrates Anondita Medicare's robust financial health and growth trajectory.

The successful IPO and strong financials position Anondita Medicare for potential expansion and increased market presence. Investors and market watchers will be keenly observing the company's performance post-listing on the NSE SME platform.